Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype

Human Immunology

Volumn 59, Issue 3, 1998, Pages 149-157

  Ou, Dawei ^a   Mitchell, Leslie Ann ^a   Décarie, Diane ^a   Tingle, Aubrey J ^a   Nepom, Gerald T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; HLA DR ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; COMPLEX FORMATION; CYTOTOXICITY; EPITOPE MAPPING; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN CONFORMATION; RUBELLA; T LYMPHOCYTE ACTIVATION; VIRUS CAPSID;

AMINO ACID SEQUENCE; AMINO ACIDS; CAPSID; CELL LINE, TRANSFORMED; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; RUBELLA VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031917272     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00006-8     Document Type: Article

References (34)

1. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A. Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells . Eur J Immunol. 19:1989;2237.
2. Olson RR, Reuter JJ, McNicholl J, Alber C, Klohe E, Callahan K, Siliano RF, Karr RW. Acidic Residues in the DRβ chain third hypervariable region are required for stimulation of a DR(α,β1*0402)-restricted T-cell clone. Hum Immunol. 41:1994;193.
3. Martinez-Soria E, Steimle V, Burkhardt C, Beffy P, Tiercy J-M, Epplen JT, Mach B, Irle C. An HLA-DRB α-helix motif share by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell lines. Hum Immunol. 40:1994;279.
4. + cytotoxic T cell clones reactive to capsid antigen of rubella virus. Virol. 191:1992;680.
5. Ou D, Mitchell LA, Ho M, Décarie D, Tingle AJ, Nepom GT, Lacroix M, Zrein M. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelop protein influence of HLA-DR polymorphism of T-cell clonal recognition . Hum Immunol. 39:1994;177.
6. + cytotoxic T-cell clones. J Virol. 66:1992;6788.
7. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wlley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215.
8. Fu X-T, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW. Pocket 4 of the HLA-DR (α,β1*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med. 181:1995;915.
9. Olson RR, De Magistris MT, Di Tommaso A, Karr RW. Mutations in the third, but not the first or second, hypervariable regions of DR(β1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol. 148:1992;2703.
10. Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, Aguilar B, Devaux B, Rothbard JB. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J Immunol. 152:1994;4946.
11. Ou D, Mitchell LA, Domeier ME, Tsang AOW, Décarie D, Tingle AJ, Nepom GT, Lacroix M, Zrein M. Characterization of HLA restrictive elements of rubella virus-specific cytotoxic T-cell clone influence of LA-DR4β chain residue 74 polymorphism on Ag peptide-T cell interaction . Int Immunol. 8:1996;1577.
12. Ou D, Chong P, Tripet B, Gillam S. Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides. J Virol. 66:1992;1674.
13. Clarke DM, Loo TM, Hui I, Chong P, Gillam S. Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C. Nucleic Acids Res. 15:1987;3041.
14. Ou D, Chong P, Tingle AJ, Gillam S. Mapping T-cell epitope of rubella virus structural proteins E1, E2 and C recognized by T-cell lines and clones derived from infected and immunized populations. J Med Virol. 40:1993;175.
15. Hiraiwa A, Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, Hansen JA, Radka SF, Nepom GT. Structural requirements for recognition of the HLA-Dw14 class II epitope a key HLA determinant associated with rheumatoid arthritis . Proc Natl Acad Sci USA. 87:1990;8051.
16. Kovats S, Drover S, Marshall WH, Freed D, Whiteley PE, Nepom GT, Blum JS. Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in Bare Lymphocyte Syndrome. J Exp Med. 179:1994;2017.
17. Brodsky FM, Parham P. Monomorphic anti-HLA-A. B. C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol. 128:1982;129.
18. Lampson LA, Levy R. Two population of Ia-like molecules on a human B cell line. J Immunol. 125:1980;293.
19. Giles RC, Nunez G, Hurley CK, Nunez-Roldan A. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med. 157:1983;1461.
20. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences. Hum Immunol. 35:1992;1.
21. Nepom BS, Nepom GT. Polyglot and polymorphism an HLA update . Arthritis Rheum. 38:1995;1715.
22. Ou D, Mitchell LA, Tingle AJ. HLA-DR restrictive supertypes dominate promiscuous T cell recognition association of multiple HLA-DR molecules with susceptibility to autoimmune diseases . J Rheumatol. 24:1997;253.
23. Wan X-L, Kimura K, Dong R-P, Honda K, Tamai H, Sasazuki T. HLA-A and -DRB4 gene in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol. 42:1995;131.
24. Hawkins BR, Lam KSL, Ma JTC, Wang C, Yeung RTT. Strong association between HLA DRw9 and Hashimoto's thyroiditis in southern Chinese. Endocrinologica. 114:1987;543.
25. Wang FW, Yu ZQ, Xy JJ, Wang XL, Zhang DQ, Chen JL. HLA and hypertrophic Hashimoto's thyroiditis in Shanghai Chinese. Tissue Antigen. 32:1988;235.
26. Malcherek G, Gnau V, Stevanovic S, Rammensee H-G, Lung G, Melms A. Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J Immunol. 153:1994;1141.
27. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules a mechanism for MHC-linked susceptibility to human autoimmune diseases . J Exp Med. 181:1995;1597.
28. Rammensee H-G. Chemistry of peptides associated with MHC class I and class II molecules. Current Opini Immunol. 7:1995;85.
29. Reay PA, Kantor RM, Davis MM. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome C(93-103). J Immunol. 152:1994;3946.
30. Rao VP, Balasa B, Carayanniotis G. Mapping of thyroglobulin epitopes presentation of a 9 mer pathogenic peptide by different mouse MHC class II isotypes . Immunogenetics. 40:1994;352.
31. Carayanniotis G, Rao VP. Searching for pathogenic epitopes in thyroglobulin parameters and caveats . Immunol Today. 18:1997;83.
32. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigalia F. Peptide binding specificity of HLA-DR4 molecules correlation with rheumatoid arthritis association . J Exp Med. 181:1995;1847.
33. O'Sullivan D, Arrhenius T, Sidney J, del Guercio MF, Albertson M, Wall M, Oseroff C, Southwood S, Colon SM, Gaeta FCA, Sette A. On the interaction of promiscuous antigenic peptides with different DR alleles identification of common structural motifs . J Immunol. 147:1991;2663.
34. Fujisao S, Matsushita S, Nishi T, Nishimura Y. Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library. Hum Immunol. 45:1996;131.